Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.19.3
Segment Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Revenues $ 383,216 $ 413,503 $ 1,067,107 $ 1,217,509  
Depreciation and amortization 144,919 135,628 430,039 383,603  
Interest expense 11,198 25,205 60,300 287,123  
Net loss (4,334,058) (2,403,251) (13,277,810) (5,298,035)  
Identifiable long-lived tangible assets 8,400,573   8,400,573   $ 8,129,440
Real property operating [Member]          
Revenues 264,141 272,444 795,656 847,939  
Depreciation and amortization 41,121 32,624 122,682 97,873  
Interest expense 25,205 32,877 287,123  
Net loss (3,190) 542 (105,569) (231,541)  
Identifiable long-lived tangible assets 7,791,863   7,791,863   7,898,224
Medical related consulting services-related parties [Member]          
Revenues 108,520 71,398 234,214 213,394  
Depreciation and amortization 550 4,706 4,037 12,703  
Net loss (200,832) (75,484) (445,529) (232,502)  
Identifiable long-lived tangible assets 270,177   270,177   6,852
Development services and sales of developed products [Member]          
Revenues 10,555 69,661 37,237 156,176  
Depreciation and amortization 103,248 98,298 303,320 273,027  
Net loss (1,163,250) (146,451) (1,641,438) (443,479)  
Identifiable long-lived tangible assets 338,533   338,533   $ 224,364
Other [Member]          
Interest expense [1] 11,198 27,423  
Net loss [1] $ (2,966,786) $ (2,181,858) $ (11,085,274) $ (4,390,513)  
[1] The Company does not allocate any interest expense and general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.